News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Algeta to Participate in Upcoming Investor Conferences


2/20/2013 9:17:22 AM

OSLO, NORWAY--(Marketwire - February 20, 2013) - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces that members of its senior management team will participate in the following upcoming investor conferences:

Citi Global Healthcare Conference 2013

Date: 25-27 February 2013

Participants:

Jeff Albers (President, Algeta US)

Mike Booth (IR)

Panel date & time: Tuesday 25 February, 2013, 10:20am EST

Venue: New York, NY, USA


Credit Suisse Global Healthcare One-on-One Conference

Date: 5-6 March 2013

Participants:

Andrew Kay (President & CEO)

Oystein Soug (CFO)

Mike Booth (IR)

Venue: London, UK


Carnegie Nordic Healthcare Seminar

Date: 12 March 2013

Participants:

Thomas Ramdahl (EVP & CTO)

Renate Birkeli (IR)

Presentation date & time: Tuesday 12 March, 2013, 10:05am CET

Venue: Stockholm, Sweden



Presentations, where applicable, will be available to download at www.algeta.com following these events.

###

About Algeta

Algeta is a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit www.algeta.com.

Press release:

http://hugin.info/134655/R/1679224/548304.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Algeta ASA via Thomson Reuters ONE

[HUG#1679224]


For further information, please contact:

Mike Booth / Renate Birkeli
+47 23 00 67 32
Communications & Corporate Affairs
Email Contact

Media enquiries:
Mark Swallow
+44 207 638 9571

Citigate Dewe Rogerson
Email Contact

Knut Ekern
+47 22 04 82 00

Gambit Hill & Knowlton
Email Contact

Kari Watson
+1 781 235 3060

MacDougall Biomedical Communications
Email Contact

US investor enquiries:
Tricia Swanson
+1 646 378 2953

The Trout Group
Email Contact


Read at BioSpace.com

comments powered by Disqus
Algeta
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES